The role of chronic self-propagating glial responses in neurodegeneration: Implications for long-lived survivors of human immunodeficiency virus

Journal of NeuroVirology

Volumn 3, Issue 4, 1997, Pages 241-246

  Mrak, Robert E ^a,b   Griffin, W Sue T ^a,b,c,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

AIDS; Alzheimer's disease; Astrocytes; Inflammation; Interleukin 1; Microglia; S100

Indexed keywords

CYTOKINE;

ALZHEIMER DISEASE; DEMENTIA; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030874069     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289709029465     Document Type: Review

References (52)

1. Barger SW, Smith-Swintosky VL, Rydel RE, Mattson M (1993). β-Amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease. Ann New York Acad Sci 695: 158-164.
2. Barnum SR, Jones JL (1995). Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci Lett 197: 121-124.
3. Breteler MM, de Groot RR, van Romunde LK, Hofman A (1995). Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study. Am J Epidemiol 142: 1300-1305.
4. Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SE, Greengard P (1992). Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89: 10075-10078.
5. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L (1988). Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38: 1682-1688.
6. 1-antichymotrypsin and apolipoprotein E is induced in astrocytes by IL-1. Neuron 14: 447-456.
7. Dinarello CA, Wolff SM (1993). The role of interleukin-1 in disease. N Engl J Med 328: 106-113.
8. Edwards JK, Larson EB, Hughes JP, Kukull WA (1991). Are there clinical and epidemiological differences between familial and non-familial Alzheimer's disease? J Amer Geriat Soc 39: 477-483.
9. Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N (1992). Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Mol Brain Res 16: 128-134.
10. Gautrin D, Gauthier S (1989). Alzheimer's disease: environmental factors and etiologic hypotheses. Can J Neurol Sci 16: 375-387.
11. Gentleman S, Roberts G (1992). Risk factors in Alzheimer's disease. Br Med J 304: 118-119.
12. Gentleman SM, McKenzie JE, Royston MC, Griffin WST, Graham DI (1997). S100β immunoreactivity in the hippocampus following fatal head injury: effect of survival time. J. Neurotoxicol 17: in press.
13. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB (1988). Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8: 2485-2490.
14. Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RG, Jacobsen JS, Vitek MP, Gajdusek DC (1989). Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86: 7606-7610.
15. Graham DI, Gentleman SM, Lynch A, Landon M, Roberts GW (1995). Distribution of beta amyloid protein in the brain following severe head injury. Neuropath Appl Neurobiol 1: 27-34.
16. Graham DI, Gentleman SM, Nicoll JAR, Rovston NC, McKenzie JE, Roberts GW, Mrak RE, Griffin WST (1997). Is there a genetic basis for β-amyloid deposition after fatal head injury? Cell Molec Neurobiol (in press).
17. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, Raskind M (1990). The association between head trauma and Alzheimer's disease. Amer J Epidemiol 131: 491-501.
18. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL III, Araoz C (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86: 7611-7615.
19. Griffin WST, Sheng JG, Gentleman SM, Graham DI, Mrak RE, Roberts GW (1994). Microglial interleukin-1α expression in human head injury: correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 176: 133-136.
20. Griffin WST, Sheng JG, Roberts GW, Mrak RE (1995a). Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 54: 276-281.
21. Griffin WST, Yeralan O, Boop F, Rovnaghi CR, Sheng JR, Mrak RE. Van Eldik LC (1995b). Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J Neurochem 65: 228-233.
22. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (1988). Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23: 138-144.
23. Kligman D, Marshak DR (1985). Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA 82: 7136-7139.
24. Kure K, Weidenheim KM, Lyman WD, Dickson DW (1990). Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol (Berl) 80: 393-400.
25. Lohler J (1988). Immunopathological reactions in viral infections of the central nervous system. J Neuroimmunol 20: 181-188.
26. Mackenzie IRA, Miller LA (1994). Senile plaques in temporal lobe epilepsy. Acta Neuropathol 87: 504-510.
27. Mackenzie IRA, Hao C, Monoz DG (1995). Role of microglia in senile plaque formation. Neurobiol Aging 16: 797-804.
28. Manuelidis EE, Manuelidis L (1989). Suggested links between different types of dementias: Creutzfeld-Jakob disease, Alzheimer disease, and retroviral CNS infections. Alzheimer Dis Assoc Discord 3: 100-109.
29. Marshak DR, Pesce SA, Stanley LC, Griffin WST (1992). Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging 13: 1-7.
30. Mayeux R, Ottman R, Tang MX, Noboa-Bauza L, Marder K, Gurland B, Stern Y (1993). Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann Neurol 33: 494-501.
31. McKenzie J, Gentleman SM, Sheng JG, Mann DMA, Mrak RE, Griffin WST, Royston MC (1997). Astrocytic S100β deposition in Down's syndrome: relationship with age and β-amyloid. Submitted for publication.
32. Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA et al (1991). Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies, EURODEM Risk Factors Research Group. Int J Epidemiol 20: S28-35.
33. Mrak RE, Sheng JG, Griffin WST (1995). Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Human Pathol 26: 816-823.
34. Mrak RE, Sheng JG, Griffin WST (1996a). Correlation of astrocytic S100β expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 55: 273-279.
35. + microglia, increase with age in normal human brain. Soc Neurosci Abstr 22 (Part 1): 213.
36. Nicoll JAR, Roberts GW, Graham DI (1995). Apolipoprotein E εA allele is associated with deposition of amyloid β-protein following head injury. Nature Med 1: 135-137.
37. Roberts GW, Gentleman SM, Lynch A, Graham DI (1991). βA-4 amyloid protein deposition in brain after head trauma. Lancet 338: 1422-1423.
38. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI (1994). β-Amyloid protein disposition in the brain following severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiat 7: 419-425.
39. Roberts GW, Gentleman SM, Stefan MD, Royston MC (1993). Alzheimer's disease: Prospects for treatment. Lancet 341: 432.
40. Royston MC, Rothwell NJ, Roberts GW (1992). Alzheimer's disease: Pathology to potential treatments? Trends Pharmacol Sci 13: 131-133.
41. Sheng JG, Boop FR, Mrak RE, Griffin WST (1994a). Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1α in microglia. J Neurochem 63: 1872-1879.
42. Sheng JG, Mrak RE, Griffin WST (1994b). S100β protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res 39: 398-404.
43. Sheng JG, Mrak RE, Rovnaghi CR, Kozlowska E, Van Eldik LJ, Griffin WST (1996a). Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging 17: 359-363.
44. Sheng JG, Ito K, Skinner RD, Mrak RE, Rovnaghi CR, Van Eldik LJ, Griffin WST (1996b). In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol Aging 17: 761-766.
45. Sheng JG, Mrak RE, Griffin WST (1995). Microglial interleukin-1α expression in brain regions of Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 21: 290-301.
46. + astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 56: 285-290.
47. Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang SX, Marshak DR, Nelson SJ, Griffin WST (1994). Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 53: 231-238.
48. van Duijn CM, Tanja TA, Haaxma R, Schulte W, Saan RJ, Lameris AJ, Antonides-Hendriks G, Hofman A (1992). Head trauma and the risk of Alzheimer's disease. Amer J Epidemiol 135: 775-782.
49. Van Eldik LJ, Griffin WST (1994). S100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochem Biophvs Acta 39: 398-404.
50. Williams DB, Annegers JF, Kokmen E, O'Brien PC, Kurland LT (1991). Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis. Neurol 41: 1554-1557.
51. Wisniewski KE, Wisniewski HM, Wen GY (1985). Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17: 278-282.
52. Yankner BA, Duffy LK, Kirschner DA (1990). Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250: 279-282.